Influence of Elevated Levels of C-Reactive Protein on Circulating Endothelial Progenitor Cell Function

Clinical and Translational Science

Volumn 7, Issue 2, 2014, Pages 137-140

  Fasing, Kevin A ^a   Nissan, Benjamin J ^a   Greiner, Jared J ^a   Stauffer, Brian L ^a,b,c   Desouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; CRP; Progenitor cells

Indexed keywords

C REACTIVE PROTEIN; CASPASE 3; STAUROSPORINE; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL MIGRATION ASSAY; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CULTURE TECHNIQUE; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NORMAL VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM; CELL MOTION; CFU COUNTING; METABOLISM; MIDDLE AGED;

C-REACTIVE PROTEIN; CELL MOVEMENT; COLONY-FORMING UNITS ASSAY; ENDOTHELIAL PROGENITOR CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899642965     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/cts.12137     Document Type: Article

References (30)

1. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. May 29 2007;49(21): 2129-2138.
2. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. Jul 2004;44(1): 6-11.
3. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. Jan 2005;14(1): 33-37.
4. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. May 2 2006;113(17):2135-2150.
5. Dimmeler S, Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med. Oct 2004;82(10): 671-677.
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. Aug 6 1999;85(3): 221-228.
7. Suh W, Kim KL, Choi JH, Lee YS, Lee JY, Kim JM, Jang HS, Shin IS, Lee JS, Byun J, et al. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun. Aug 13 2004;321(1): 65-71.
8. Pearson TA, Bazzarre TL, Daniels SR, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Hong Y, Mensah GA, Sallis JF Jr., et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. Feb 4 2003;107(4): 645-651.
9. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. Nov 14 2002;347(20): 1557-1565.
10. Kushner E, Van Guilder G, Maceneaney O, Greiner J, Cech J, Stauffer B, Desouza G. Research Letter. Age Ageing. 2010; 39(2): 268-272.
11. Kushner EJ, MacEneaney OJ, Weil BR, Greiner JJ, Stauffer BL, DeSouza CA. Aging is associated with a proapoptotic endothelial progenitor cell phenotype. J Vasc Res. 2011;48(5): 408-414.
12. Hoetzer GL, Van Guilder GP, Irmiger HM, Keith RS, Stauffer BL, DeSouza CA. Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men. J Appl Physiol. Mar 2007;102(3): 847-852.
13. Ridker P, Rifai N, Stampfer M, Hennekens C. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101: 1767-1772.
14. Kunz GA, Liang G, Cuculi F, Gregg D, Vata KC, Shaw LK, Goldschmidt-Clermont PJ, Dong C, Taylor DA, Peterson ED. Circulating endothelial progenitor cells predict coronary artery disease severity. Am Heart J. Jul 2006;152(1): 190-195.
15. Vasa M, Fichtlscher S, Aicher A, Alder K, Urbich C, Martin H, Zeiher A, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research. 2001;89: e1-e7.
16. MacEneaney OJ, Kushner EJ, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA. Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. Int J Obes (Lond). Feb 2009;33(2): 219-225.
17. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol. Nov 2006;26(11): 2476-2482.
18. Lafuente N, Azcutia V, Matesanz N, Cercas E, Rodrigues-Manas L, Sanchez-Ferrer CF, Peiro C. Evidence for sodium azide as an artifact mediating the modulation of inducible nitric oxide synthase by C-reactive protein. J Cardiovasc Pharmacol. Mar 2005;45(3): 193-196.
19. Taylor KE, Giddings JC, vanden Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol. Jun 2005;25(6): 1225-1230.
20. Liu C, Wang S, Deb A, Nath KA, Katusic ZS, McConnell JP, Caplice NM. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ Res. Jul 22 2005;97(2): 135-143.
21. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation. May 2 2006;113(17): 2128-2134.
22. Ahrens I, Domeij H, Eisenhardt SU, Topcic D, Albrecht M, Leitner E, Viitaniemi K, Jowett JB, Lappas M, Bode C, et al. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Res Cardiol. Sep 2011;106(5): 879-895.
23. Pepys MB. CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol. Jun 2005;25(6): 1091-1094.
24. Khreiss T, Jozsef L, Potempa LA, Filep JG. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. Apr 27 2004;109(16): 2016-2022.
25. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. Mar 1 2007;109(5): 1801-1809.
26. Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH, Kim TY, Kim JY, Kang HJ, Chae IH, Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation. Oct 9 2007;116(15): 1671-1682.
27. Ito H, Rovira I, Bloom M, Takedo K, Ferrans V, Quyyumi A, Finkel T. Endothelial progenitor cells a putative target for angiostatin. Cancer Research. 1999;59: 5875-5877.
28. Chade AR, Zhu X, Lavi R, Krier JD, Pislaru S, Simari RD, Napoli C, Lerman A, Lerman LO. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation. Feb 3 2009;119(4): 547-557.
29. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. Sep 8 2005;353(10): 999-1007.
30. Hill J, Zalos G, Halcox J, Schenkne W, Waclawiw M, Quyyumi A, Finkel T. Circulating endothelial progenitor cells, vascular fuinction, and cardiovascular risk. N Engl J Med. 2003;348: 593-600.